SG Americas Securities
CLPT icon

SG Americas Securities’s ClearPoint Neuro CLPT Stock Holding History

SG Americas Securities’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-372,356
Closed -$3.39M – 3396
2026
Q1 		$3.39M Buy
+372,356
New +$4.7M ﹤0.01% 1177
2025
Q4 		– Sell
-5,079
Closed -$111K – 3625
2025
Q3 		$111K Buy
+5,079
New +$59.8K ﹤0.01% 3037
2023
Q4 		– Sell
-16,529
Closed -$83K – 3147
2023
Q3 		$83K Buy
+16,529
New +$98.4K ﹤0.01% 2838
2023
Q2 		– Sell
-14,615
Closed -$123K – 2424
2023
Q1 		$123K Buy
+14,615
New +$128K ﹤0.01% 2779
2021
Q4 		– Sell
-6,479
Closed -$115K – 3427
2021
Q3 		$115K Buy
+6,479
New +$121K ﹤0.01% 3600

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

SG Americas Securities's CLPT Position: Q2 2026 in Review

SG Americas Securities sold out of ClearPoint Neuro (CLPT) in Q2 2026, closing a stake of 372,356 shares — an estimated $3.39M sold.

SG Americas Securities first reported a position in CLPT in Q3 2021 and held it in 5 quarters. The position peaked at $3.39M in Q1 2026. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • SG Americas Securities reported no remaining ClearPoint Neuro position as of Q2 2026 after selling out during the quarter.
  • SG Americas Securities sold 372,356 ClearPoint Neuro shares in Q2 2026, an estimated $3.39M.
  • SG Americas Securities first reported a position in ClearPoint Neuro in Q3 2021 and held it in 5 quarters.
  • SG Americas Securities's ClearPoint Neuro position peaked at $3.39M in Q1 2026.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.